ArticleCurrent medical imaging2026
An Efficient and Cohesive System for Enhanced Accuracy in Malignant Brain Tumor Diagnosis.
Article in Current medical imaging, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
INTRODUCTION/
objectiveBrain tumors present a significant health challenge, making an accurate diagnosis crucial for effective treatment and improved patient outcomes. This study aims to develop SCSFE-DiagBT, an advanced deep learning framework that integrates classification and segmentation. It is designed for enhanced brain tumor diagnosis using MRI scans.
methodsWe propose a Stacked Classification and Segmentation Model with Feature Extraction (SCSFE-DiagBT). This model unifies the processes of classification and segmentation into a single diagnostic pipeline. It leverages the complementarity of both tasks by employing a deep learning approach to efficiently analyze MRI scans.
resultsExperimental results indicate substantial improvements in performance metrics. In classification, metrics such as accuracy, precision, and recall improved by up to 31% compared to baseline models, with high accuracy. For segmentation, the model achieved a 12% improvement in the Dice coefficient, reaching an accuracy of 99.58% and a Dice score of 86.30%. This demonstrates robust generalization and minimal overfitting. DISCUSSION: The findings underscore the effectiveness of integrating classification and segmentation in the diagnosis of brain tumors. The enhanced interpretability through feature extraction further supports the model's utility in clinical settings, potentially reducing diagnostic variability associated with manual interpretations.
conclusionSCSFE-DiagBT emerges as a highly accurate and viable tool for brain tumor diagnosis. It offers significant advancements over traditional methods and promising implications for improving patient care and outcomes in neuro-oncology.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.